Skip to content
Open access

Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics

Sep 2026 · bioRxiv · 0 citations · 33 references
Biology
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.